PodParley PodParley
DTB Podcast cover art

All Episodes

DTB Podcast — 188 episodes

#
Title
1

Understanding clinical significance, and the new epinephrine nasal spray

2

GLP-1 drugs, reducing sedative use, and a thank you

3

Disinformation and misinformation, AI in primary care and antidepressant tapering

4

Prevention in primary care, elinzanetant for menopause, and a farewell to David.

5

Medicines - but at what cost, direct penicillin allergy challenge, and prescribing mistakes

6

Orphan drugs, allopurinol and CVD, mavacamten for obstructive hypertrophic cardiomyopathy

7

Antibiotic susceptibility reports, deprescribing, and heart failure drugs

8

AI and DTB, drug safety, tirzepatide, and lecanemab for Alzheimer's disease

9

National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis

10

Identifying VTE in early pregnancy, gabapentinoids and COPD, managing ADHD

11

The polypill revisited, cytisinicline for vaping cessation and a new co-host

12

Misuse of female empowerment to sell tests and treatments, triptan safety, use of ACEI or AIIRA in CKD

13

Paying the price, liver problems with fezolinetant, systemic anticancer treatments

14

Prioritising shared decision making, remission from type 2 diabetes, gefapixant for cough

15

PILs: all harms and no benefits, Irish College of GPs end pharma funding, Ryeqo for fibroids

16

When it comes to drugs, sex matters; menopausal HT and dementia; daridorexant for sleep

17

Supporting obesity treatment, major bleeds with anticoagulants and SSRIs, equity in COPD care

18

(Un)common sense in oncology, DOACs in device-detected AF, and hypertension in the elderly

19

Medicines optimisation measures, warfarin-tramadol interaction and icosapent ethyl

20

Psychotropic medicines in children, warfarin vs DOAC in old age, and fezolinetant in menopause

21

Propranolol and its risk in overdose and managing COPD exacerbations

22

Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

23

Medicines and global warming, donanemab for AD, and cytisine for smoking cessation

24

Drug safety alerts, valproate safety (again) and a new contraceptive POP

25

Protecting consumers, tramadol-warfarin interaction and very low calorie diets

26

ADHD medicines shortages, fluoroquinolone safety, drugs not to prescribe

27

Continuity of care, statins and myasthenia gravis, and acne

28

Rationalising blood tests, bempedoic acid and CV outcomes and semaglutide for obesity

29

BNF moving with the times; preventable deaths; plus an intro to pharmacogenetics

30

Taxing ill health, and what evidence for intravenous vitamins?

31

NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity

32

FeNO and asthma, low-dose aspirin and H pylori eradication, plus finerenone

33

July 2023: Whither evidence, COI in guidelines, isotretinoin safety, SGLT2 inhibitors and Utrogestan shortage

34

DTB 60th anniversary podcast interview - Barbara Mintzes

35

Aciclovir PEP after VZ exposure in pregnancy, falls and fractures with aspirin, an inclisiran rant

36

May 2023 - another DTB celebration (or two), OACs and NSAIDs, and siRNA-based therapeutics

37

When should you take antihypertensive medication. Prescribing for skin conditions in pregnancy

38

DTB 60th anniversary podcast interview - Joanna Girling

39

Penicillin allergy, lecanemab and Alzeimer’s disease, a new oral contraceptive and statins for all

40

Swapping to edoxaban, DOACs in renal impairment, inflammatory rheumatic diseases in pregnancy

41

DTB 60th anniversary podcast interview - John Dowden

42

Happy New Year, sad news from Australia, toxocarosis in humans and yet more on valproate safety

43

December 2022 - MHT and ’brain fog’, risks from sodium-containing paracetamol and 2022 revisited

44

DTB 60th anniversary podcast interview - Jo Congleton

45

November 2022 - FMT, methotrexate and COVID vaccine boosters, and Palforzia for peanut allergy

46

October 2022 - two freebies, advertising woes, paracetamol (again) and standing up to Pharma

47

September 2022 - healthcare costs, gout, metformin and B12, more on COI and carbetocin

48

August 2022 - COI, STOMP/STAMP, BP deprescribing, amiodarone and bempedoic acid

49

July 2022 - an e-letter, estradiol, APPGs, inclisiran and nitrofurantoin

50

June 2022 - a complaint, primary care spirometry, paracetamol and frailty, serotonin syndrome

51

May 2022 - an apology, international drug bulletins, mirtazapine and oral antivirals for covid-19

52

DTB turns 60! Plus: conflicts of interest, harms from nitrofurantoin and hypertension in pregnancy

53

March 2022 - Paracetamol and blood pressure, greener inhalers, harms from medicines and naldemedine

54

Overprescribing, overuse of short-acting beta agonists, inflammatory bowel disease in pregnancy

55

January 2022 - Molnupiravir, potentially harmful prescribing and antidepressant withdrawal reactions

56

Dec 2021 - Overprescribing, BP monitor accuracy, topical steroids, and bremelanotide and flibanserin

57

November 2021 - Drugs to avoid, penicillin allergy and a new drug for osteoporosis

58

October 2021 - Desogestrel POM to P, PCI in stable IHD, and migraine in pregnancy

59

September 2021: Aducanumab for Alzheimer’s, antibiotics, shared-decision making, and dental health

60

August 2021. Community pharmacy discharge medicines service: a step towards improved patient safety?

61

July 2021 - Chloramphenicol eye drops, boron, infants and fertility

62

June 2021 - COVID-19 vaccination in pregnancy

63

May 2021 - Time for transparency

64

April 2021 - Asthma, a disease of variability

65

March 2021 - Opioid safety: striking the right balance

66

February 2021 - Why vaccines matter

67

January 2021 - COVID-19 vaccination: we need more than the ‘mum test’

68

COVID-19 vaccines - getting the information right

69

December 2020 - Hype and hope of bedtime dosing of antihypertensives

70

November 2020 - Chronic pain (analgesia armageddon)

71

October 2020 - Making medicines safer?

72

September 2020 - Dilemmas in commissioning biological therapies

73

August 2020 - Virtual revolution

74

Low-dose aspirin for prevention of pre-eclampsia: when over the counter just isn’t

75

Deprescribing in the time of COVID-19

76

Improving consultations with children and adolescents, plus treating Covid-19 with ibuprofen

77

April 2020 - Lung volume in COPD: when less is more

78

March 2020 - Dapagliflozin for type 1 diabetes: ensuring benefits outweigh the risks

79

February 2020 - Registering our interest

80

Melatonin for jet lag

81

January 2020 - Polypharmacy and deprescribing: just ask the patient

82

December 2019 - Has the polypill finally proven its worth?

83

November 2019 - Meeting QOF hypertension targets but failing the patient

84

October 2019 -Medicines optimisation: time to review fibrates?

85

September 2019 - Social prescribing: right idea, wrong name?

86

August 2019: Time to speed up the diagnosis of pre-eclampsia

87

July 2019: It is hard work being a patient

88

June 2019: If the drugs don’t work

89

May 2019: The new GP contract - an opportunity for drugs and therapeutics

90

April 2019: DOAC dosing in renal impairment

91

March 2019: A new direction for diabetes

92

February 2019: The past, present and future of inhaled corticosteroids for COPD

93

January 2019: Challenging the supremacy of intravenous antibiotics

94

December 2018: Information on medicines for patients

95

November 2018: Travelling with medicines

96

October 2018: atrial fibrillation, opioids for chronic pain and over-the-counter sildenafil

97

Here’s your New DTB!

98

August 2018: what’s your position on giving birth?

99

July 2018: managing herbal-drug interactions

100

June 2018: Antidepressants - there is no news

101

May 2018: Does pulmonary rehabilitation need more PR?

102

April 2018: STOMP - time to make more noise

103

March 2018: Do hypertension guidelines put the person first?

104

February 2018: Clinical guidelines - more PDAs please

105

January 2018: No alchemy for obesity

106

December 2017: Shared care protocols – have they had their day?

107

November 2017: Prescribing in pregnancy - stop stopping and start planning

108

October 2017: Flagging risk

109

September 2017: Vitamin D and adolescents: a forgotten ‘at risk’ group?

110

August 2017: What price drugs online?

111

July 2017: The good, the bad and the ugly

112

June 2017: Turning the tide of high-dose inhaled corticosteroids

113

May 2017: Rational rationing in the NHS?

114

April 2017: Prevention of type 2 diabetes - where do you draw the line?

115

March 2017: Better PrEParation needed?

116

February 2017: Spironolactone - potion or poison?

117

January 2017: Sore throat test and treat - a £34 million question?

118

December 2016: Wise words on prescription of medicines and treatment decisions

119

November 2016: Rubella immunisation. Check vaccination history

120

October 2016: the dangers of a quicker authorisation process for drugs

121

September 2016: Last orders for nalmefene in the management of alcohol dependence?

122

August 2016: Better guidelines. Capsaicin for diabetic neuropathy. Excipients in medicines

123

July 2016: Where next for rationing medicines? Vitamins during pregnancy: a big marketing campaign?

124

June 2016: Problems with botanicals; a new drug for heart failure; frailty and deprescribing

125

May 2016: supporting learning disabilities; new drugs for orthostatic hypotension and ADHD

126

April 2016: the cancer drugs fund for England, restless legs and animal-derived content in medicines

127

March 2016 Issue: Testosterone replacement therapy and a new antidepressant

128

February 2016 issue: Too many options, too little choice in COPD?

129

January 2016 issue: NHS Health Checks, Adolescent Adherence and Management of Dry Eye

130

December 2015 issue: Cost-effectiveness of drugs on long term conditions

131

In this issue: November 2015

132

In this issue: September 2015

133

In this issue: October 2015

134

In this issue: August 2015

135

In this issue - July 2015

136

In this issue - June 2015

137

In this issue - May 2015

138

In this issue - April 2015

139

In this issue - February 2015

140

In this issue - March 2015

141

In this issue - January 2015

142

In this issue - December 2014

143

In this issue - November 2014

144

In this issue - October 2014

145

In this issue - September 2014

146

In this issue - August 2014

147

In this issue - July 2014

148

In this issue: June 2014

149

In this issue - May 2014

150

In this issue - April 2014

151

In this issue - March 2014

152

In this issue - February 2014

153

In this issue - August 2011

154

In this issue - July 2011

155

In this issue - June 2011

156

Sunscreens

157

In this issue - May 2011

158

In this issue - April 2011

159

In this issue - March 2011

160

In this issue - January 2011

161

In this issue - February 2011

162

In this issue - December 2010

163

In this issue - November 2010

164

In this issue - October 2010

165

In this issue - September 2010

166

Mixtard 30

167

In this issue - July 2010

168

In this issue - August 2010

169

In this issue - June 2010

170

In this issue - April 2010

171

In this issue - May 2010

172

Herbal medicines – what do clinicians know?

173

In this issue - March 2010

174

In this issue - February 2010

175

In this issue - January 2010

176

In this issue - December 2009

177

In this issue - November 2009

178

In this issue - October 2009

179

In this issue - September 2009

180

Tamiflu - the wrong message?

181

In this issue - August 2009

182

In this issue - July 2009

183

In this issue - June 2009

184

Real costs of end-of-life drugs

185

In this issue - May 2009

186

In this issue - April 2009

187

What are you on?

188

Mole checks on the high street